| DAA936 |
Volume of hematopoietic bone marrow decreases |
Physiological |
bone marrow |
Human |
— |
— |
|
| DAA1961 |
Intracellular NAD+ concentration decreases |
Molecular |
bone marrow |
Mouse |
— |
— |
|
| DAA935 |
Pro-B cell generation and differentiation declines |
Physiological |
bone marrow, B cell |
Human |
— |
— |
|
| DAA1959 |
Osteoblast differentiation decreases |
Physiological |
bone marrow |
Mouse |
— |
— |
|
| DAA934 |
Number of mature B cells leaving the bone marrow declines |
Physiological |
bone marrow, B cell |
Human |
— |
— |
|
| DAA1962 |
Sirt1 activity decreases |
Molecular |
bone marrow |
Mouse |
Sirt1 |
— |
|
| DAA1073 |
Fewer cells and higher apoptosis |
Physiological |
bone marrow |
Human |
— |
— |
|
| DAA1960 |
Adipocyte formation increases |
Physiological |
bone marrow |
Mouse |
— |
— |
|
| DAA2027 |
DNA damage acummulates in hematopoietic stem and progenitor cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
| DAA1991 |
Hematopoietic cells accumulate random mutations |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
| DAA932 |
Renewal capacity declines |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
| DAA2035 |
Alterations in frequency, developmental potential and gene expression profile in hematopoietic stem cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
| DAA2014 |
Microsatellite instability in hematopoietic stem cells and progenitor cells |
Physiological |
hematopoietic stem cells |
Human |
MLH1 |
— |
|
| DAA673 |
telomere length in hematopoietic stem cells |
Molecular |
hematopoietic stem cells |
Human |
— |
— |
|
| DAA678 |
Capacity of mesenchymal stem cells to differentiate into osteoblasts may be decreased |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
| DAA2437 |
dehydrogenase/reductase (SDR family) member 3 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
DHRS3 |
18.6% Decrease DNA Methylation |
|
| DAA2433 |
cyclin-dependent kinase inhibitor 2B isoform 2 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CDKN2B |
16.7% Decrease DNA Methylation |
|
| DAA2461 |
calcyphosine isoform b decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CAPS |
17.3% Decrease DNA Methylation |
|
| DAA2444 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
20.1% Decrease DNA Methylation |
|
| DAA2462 |
Level of miR-519d decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MIR519D |
44.7% Decrease miRNA Level |
|
| DAA2463 |
Level of miR-19a decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MIR19A |
40.7% Decrease miRNA Level |
|
| DAA2441 |
complement factor D preproprotein increases with age |
Molecular |
mesenchymal stem cell |
Human |
CFD |
22.2% Increase DNA Methylation |
|
| DAA2445 |
L-pipecolic acid oxidase increases with age |
Molecular |
mesenchymal stem cell |
Human |
PIPOX |
32.2% Increase DNA Methylation |
|
| DAA2449 |
microfibrillar associated protein 5 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MFAP5 |
46.4% Decrease DNA Methylation |
|
| DAA2439 |
hypothetical protein LOC283598 increases with age |
Molecular |
mesenchymal stem cell |
Human |
C14orf177 |
42.5% Increase DNA Methylation |
|